CARMAX INC
No SEC Form 4 filings for $KMX in the last 30 days.
See all $KMX insider activity →Bank of America upgraded CarMax (KMX) to Buy, raising its price target to $65. The upgrade follows CarMax's strong used vehicle sales, attributed to FTC price transparency rules. Shares rose over 3% in premarket trading. Analysts expect sustained positive sales growth and cost cuts to support further price competitiveness.
CarMax (KMX) reported Q2 2027 revenue of $7.9B, up 19.5% YoY, and EPS of $1.16, beating expectations. Sales growth and cost control drove earnings, but gross profit per vehicle declined. The company plans to resume share buybacks. Hedge fund interest increased, and the stock is up 40% YTD.
UBS raised CarMax's (KMX) price target to $62, citing Q2 FY2027 results with 13% used vehicle sales growth and gross profit per unit of $2,105. The company updated its full-year outlook and resumed share buybacks. CarMax's Q2 earnings of $1.16 per share on $7.88B revenue beat estimates. BofA Securities also raised its target to $50, maintaining an Underperform rating.
Over the past 7 days, AlphAI's AI scored 6 news stories mentioning KMX (CARMAX INC). Coverage has skewed bullish: 6 bullish, 0 neutral, and 0 bearish.
Recent KMX coverage spans earnings, market movers and financial news.
Upgrade and higher target suggest near‑term upside.
Earnings beat and strong sales likely support upside, but margin compression creates downside risk.
Analyst upgrades suggest upside potential.
Target raise suggests bullish sentiment.
Strong earnings beat likely supports price upside.
AlphAI scores every news story that mentions KMX with an AI model for sentiment and relevance, and aggregates insider trades from CARMAX INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Bank of America upgraded CarMax (KMX) to Buy, raising its price target to $65. The upgrade follows CarMax's strong used vehicle sales, attributed to FTC price transparency rules. Shares rose over 3% in premarket trading. Analysts expect sustained positive sales growth and cost cuts to support further price competitiveness.
1 min readCarMax (KMX) reported Q2 2027 revenue of $7.9B, up 19.5% YoY, and EPS of $1.16, beating expectations. Sales growth and cost control drove earnings, but gross profit per vehicle declined. The company plans to resume share buybacks. Hedge fund interest increased, and the stock is up 40% YTD.
2 min readUBS raised CarMax's (KMX) price target to $62, citing Q2 FY2027 results with 13% used vehicle sales growth and gross profit per unit of $2,105. The company updated its full-year outlook and resumed share buybacks. CarMax's Q2 earnings of $1.16 per share on $7.88B revenue beat estimates. BofA Securities also raised its target to $50, maintaining an Underperform rating.
2 min readAnalysts updated price targets for several companies. Piper Sandler raised Microsoft's target to $610, maintaining an Overweight rating. Other notable changes include Carmax, Accelerant, Jack Henry, Moderna, Grocery Outlet, Hinge Health, Aytu Biopharma, NetApp, and Ferrari.
2 min readCarMax (KMX) reported Q2 2027 earnings with total net revenues of $7.9B, up 19.5% YoY, driven by higher retail used unit sales and average selling prices. Net earnings per diluted share rose 81% to $1.16. Retail used unit sales increased 13.8% to 227,391, while wholesale vehicle unit sales rose 15.9% to 160,344. The company expects CarMax Auto Finance income to be slightly lower in FY 2027 and announced $50M in settlement-related charges by year-end.
3 min readAnalysts updated ratings and price targets for several companies. Wells Fargo downgraded Ally Financial (ALLY) to Equal Weight, reducing its target to $42. Pinnacle Financial (PNFP) was upgraded to Overweight. Carvana (CVNA) saw its target cut to $90, while Fair Isaac (FICO) and Vistra (VTR) also had targets reduced.
2 min readBloom Energy (BE) rose 12.7% after Jefferies raised its price target to $264 and Oracle (ORCL) reaffirmed a project. Carnival (CCL) jumped 11.7% on strong earnings and raised guidance. Fair Isaac (FICO) fell 26.7% due to FHFA's mortgage pricing grid change. U.S. indices were mixed, with the 10-year Treasury yield at 5.29%.
3 min readCarnival rose 12% after reporting strong Q3 earnings and bookings. Iovance Biotherapeutics surged 26% on raised revenue guidance. Bloom Energy jumped 13% following a price target increase and expansion news. Fair Isaac plunged 18% due to mortgage pricing changes. Other movers include Oracle, Bloomin' Brands, SpaceX, Summit Therapeutics, and CarMax.
3 min readPre-market futures rise moderately; Dow, Nasdaq, S&P, and Russell 2000 up. Oil prices cool, bond yields remain high. Case-Shiller reports July home price growth at +1.9%, with Chicago, NYC, and Cleveland leading. CarMax reports Q2 earnings beat, with EPS at $1.16 and revenue at $7.88B, shares up 5%.
2 min readApple may shift to more frequent product launches. Boeing shares rose 2.2% after UBS reiterated a Buy rating. Corning shares up 4% on a $3B AT&T deal. Fair Isaac shares down 26% due to mortgage pricing changes. CarMax reported 81.3% EPS growth and 19.5% revenue rise. Carnival shares jumped 12% on strong Q3 results and raised outlook.
3 min read
